Multimodal AI-driven Biomarker for Early Detection of Cancer Cachexia

• URL: http://arxiv.org/abs/2503.06797v1
• Date: Sun, 09 Mar 2025 22:32:37 GMT
• Title: Multimodal AI-driven Biomarker for Early Detection of Cancer Cachexia
• Abstract summary: Cancer cachexia is a multifactorial syndrome characterized by progressive muscle wasting, metabolic dysfunction, and systemic inflammation.<n>There is no single definitive biomarker for cachexia.<n>This study proposes a multimodal AI-based biomarker for early cancer cachexia detection.
• Score: 14.27396467108753
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Cancer cachexia is a multifactorial syndrome characterized by progressive muscle wasting, metabolic dysfunction, and systemic inflammation, leading to reduced quality of life and increased mortality. Despite extensive research, no single definitive biomarker exists, as cachexia-related indicators such as serum biomarkers, skeletal muscle measurements, and metabolic abnormalities often overlap with other conditions. Existing composite indices, including the Cancer Cachexia Index (CXI), Modified CXI (mCXI), and Cachexia Score (CASCO), integrate multiple biomarkers but lack standardized thresholds, limiting their clinical utility. This study proposes a multimodal AI-based biomarker for early cancer cachexia detection, leveraging open-source large language models (LLMs) and foundation models trained on medical data. The approach integrates heterogeneous patient data, including demographics, disease status, lab reports, radiological imaging (CT scans), and clinical notes, using a machine learning framework that can handle missing data. Unlike previous AI-based models trained on curated datasets, this method utilizes routinely collected clinical data, enhancing real-world applicability. Additionally, the model incorporates confidence estimation, allowing the identification of cases requiring expert review for precise clinical interpretation. Preliminary findings demonstrate that integrating multiple data modalities improves cachexia prediction accuracy at the time of cancer diagnosis. The AI-based biomarker dynamically adapts to patient-specific factors such as age, race, ethnicity, weight, cancer type, and stage, avoiding the limitations of fixed-threshold biomarkers. This multimodal AI biomarker provides a scalable and clinically viable solution for early cancer cachexia detection, facilitating personalized interventions and potentially improving treatment outcomes and patient survival.

Related papers

• Benchmarking Machine Learning Models for Multi-Omics-Based Breast Cancer Prediction [0.0]
  Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection.<n>This study presents a systematic benchmarking analysis of classical machine learning models for ER status prediction.
  arXiv  Detail & Related papers  (2026-06-27T02:46:40Z)
• Predicting Immune Biomarkers with MultiModal Mixture-of-Expert Pathology Foundation Models Empowers Precision Oncology [47.79180201495836]
  MixTIME is a multimodal foundation model that integrates pathology foundation models trained across distinct modalities.<n>It predicts multiplex immunofluorescence (mIF) protein expression from hematoxylin and eosin whole-slide images.<n>MixTIME achieves state-of-the-art performance across 17 protein markers as measured by correlation metrics.
  arXiv  Detail & Related papers  (2026-06-16T16:22:42Z)
• Dual-Modal Lung Cancer AI: Interpretable Radiology and Microscopy with Clinical Risk Integration [0.0]
  This study proposes a dual-modal artificial intelligence framework that integrates CT radiology with hematoxylin and eosin histopathology for lung cancer diagnosis and subtype classification.<n>The system employs convolutional neural networks to extract radiologic and histopathologic features and incorporates clinical metadata to improve robustness.<n> Experimental results show strong performance with accuracy up to 0.87, AUROC above 0.97, and macro F1-score of 0.88.
  arXiv  Detail & Related papers  (2026-04-17T14:37:54Z)
• CoDaS: AI Co-Data-Scientist for Biomarker Discovery via Wearable Sensors [44.01195029438923]
  We introduce CoDaS (AI Co-Data-Scientist), a system that structures biomarker discovery as an iterative process.<n>Across three cohorts totaling 9,279 participantobservations, CoDaS identified 41 candidate digital for mental health and 25 for metabolic outcomes.<n>CoDaS surfaced circadian instability-related features in both datasets reflected in sleep duration variability.
  arXiv  Detail & Related papers  (2026-04-16T04:47:55Z)
• Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression [9.499341016835121]
  Alzheimers disease (AD) is a complex, multifactorial neurodegenerative disorder.<n>Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.<n>Here, we present a machine learning-based operator learning framework for personalized modeling of AD progression.
  arXiv  Detail & Related papers  (2025-07-22T01:52:28Z)
• Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification, An Interpretable Multi-Omics Approach [36.92842246372894]
  Multi-Omics Graph Kolmogorov-Arnold Network (MOGKAN) is a deep learning framework that utilizes messenger-RNA, micro-RNA sequences, and DNA methylation samples. By integrating multi-omics data with graph-based deep learning, our proposed approach demonstrates robust predictive performance and interpretability.
  arXiv  Detail & Related papers  (2025-03-29T02:14:05Z)
• Reliable Radiologic Skeletal Muscle Area Assessment -- A Biomarker for Cancer Cachexia Diagnosis [12.928843687757466]
  We developed SMAART-AI, an end-to-end automated pipeline powered by deep learning models (nnU-Net 2D) SMAART-AI incorporates an uncertainty-based mechanism to flag SMA predictions for expert review, enhancing reliability. Tested on the gastroesophageal cancer dataset, SMAART-AI achieved a Dice score of 97.80% +/- 0.93%, with SMA estimated across all four datasets in this study at a median absolute error of 2.48%.
  arXiv  Detail & Related papers  (2025-03-19T19:07:59Z)
• Prediction of Lung Metastasis from Hepatocellular Carcinoma using the SEER Database [0.9055332067000195]
  Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. predictive models for lung metastasis inHCC remain limited in scope and clinical applicability. We develop and validate an end-to-end machine learning pipeline using data from the Surveillance, Epidemiology, and End Results (SEER) database.
  arXiv  Detail & Related papers  (2025-01-20T20:06:31Z)
• LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification [41.94295877935867]
  This paper introduces LASSO-MOGAT, a graph-based deep learning framework that integrates messenger RNA, microRNA, and DNA methylation data to classify 31 cancer types.
  arXiv  Detail & Related papers  (2024-08-30T16:26:04Z)
• Biomarker based Cancer Classification using an Ensemble with Pre-trained Models [2.2436844508175224]
  We propose a novel ensemble model combining pre-trained Hyperfast model, XGBoost, and LightGBM for multi-class classification tasks. We leverage a meta-trained Hyperfast model for classifying cancer, accomplishing the highest AUC of 0.9929. We also propose a novel ensemble model combining pre-trained Hyperfast model, XGBoost, and LightGBM for multi-class classification tasks, achieving an incremental increase in accuracy (0.9464)
  arXiv  Detail & Related papers  (2024-06-14T14:43:59Z)
• MMIL: A novel algorithm for disease associated cell type discovery [58.044870442206914]
  Single-cell datasets often lack individual cell labels, making it challenging to identify cells associated with disease. We introduce Mixture Modeling for Multiple Learning Instance (MMIL), an expectation method that enables the training and calibration of cell-level classifiers.
  arXiv  Detail & Related papers  (2024-06-12T15:22:56Z)
• Self-Normalizing Foundation Model for Enhanced Multi-Omics Data Analysis in Oncology [0.0]
  SeNMo is a foundation model that has been trained on multi-omics data across 33 cancer types. We trained SeNMo for the task of overall survival of patients using pan-cancer multi-omics data involving 33 cancer sites. SeNMo was validated on two independent cohorts: Moffitt Cancer Center and CPTAC lung squamous cell carcinoma.
  arXiv  Detail & Related papers  (2024-05-13T22:45:44Z)
• Optimal transport for automatic alignment of untargeted metabolomic data [8.692678207022084]
  We introduce GromovMatcher, a flexible and user-friendly algorithm that automatically combines LC-MS datasets using optimal transport. By capitalizing on feature intensity correlation structures, GromovMatcher delivers superior alignment accuracy and robustness. We show how GromovMatcher facilitates the search for biomarkers associated with lifestyle risk factors linked to several cancer types.
  arXiv  Detail & Related papers  (2023-06-05T20:08:19Z)
• A marker-less human motion analysis system for motion-based biomarker discovery in knee disorders [60.99112047564336]
  The NHS has been having increased difficulty seeing all low-risk patients, this includes but not limited to suspected osteoarthritis (OA) patients. We propose a novel method of automated biomarker identification for diagnosis of knee disorders and the monitoring of treatment progression.
  arXiv  Detail & Related papers  (2023-04-26T16:47:42Z)
• Regression-based Deep-Learning predicts molecular biomarkers from pathology slides [40.24757332810004]
  We developed and evaluated a new self-supervised attention-based weakly supervised regression method that predicts continuous biomarkers directly from images. Using regression significantly enhances the accuracy of biomarker prediction, while also improving the interpretability of the results over classification. Our open-source regression approach offers a promising alternative for continuous biomarker analysis in computational pathology.
  arXiv  Detail & Related papers  (2023-04-11T11:43:51Z)
• Many-to-One Distribution Learning and K-Nearest Neighbor Smoothing for Thoracic Disease Identification [83.6017225363714]
  deep learning has become the most powerful computer-aided diagnosis technology for improving disease identification performance. For chest X-ray imaging, annotating large-scale data requires professional domain knowledge and is time-consuming. In this paper, we propose many-to-one distribution learning (MODL) and K-nearest neighbor smoothing (KNNS) methods to improve a single model's disease identification performance.
  arXiv  Detail & Related papers  (2021-02-26T02:29:30Z)
• G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for Biomarker Identification and Disease Classification [49.53651166356737]
  We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers. We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
  arXiv  Detail & Related papers  (2021-01-27T19:28:04Z)
• Topological Data Analysis of copy number alterations in cancer [70.85487611525896]
  We explore the potential to capture information contained in cancer genomic information using a novel topology-based approach. We find that this technique has the potential to extract meaningful low-dimensional representations in cancer somatic genetic data.
  arXiv  Detail & Related papers  (2020-11-22T17:31:23Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.